Drupal.behaviors.print = function(context) {window.print();window.close();}>
Arrowhead Buys Roche RNA Drug Assets, Doubles Burn Rate with Addition of Madison Site
October 27, 2011
Arrowhead Buys Roche RNA Drug Assets, Doubles Burn Rate with Addition of Madison Site
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Arrowhead Publishes Rodent, Primate Data on Preclinical Hepatitis B Therapy
February 28, 2013 / Gene Silencing News
Arrowhead Offers Timeline for HBV Candidate, Plans Two Phase I Trials
February 14, 2013 / Gene Silencing News
Arrowhead Publishes Primate Data on Co-Delivery Approach for Cholesterol-Conjugated siRNAs
November 29, 2012 / Gene Silencing News
Arrowhead Presents Preclinical Data on HBV Candidate, Subcutaneous Delivery Tech
November 8, 2012 / Gene Silencing News
Arrowhead Takes Last Steps toward Moving HBV Drug into Human Testing
June 7, 2012 / Gene Silencing News